Dynavax Technologies Corporation (DVAX) Showing Sign Of Heavy Institutional Buying?

Dynavax Technologies Corporation (NASDAQ:DVAX) enjoyed a 40.89% run-up in share price since hitting record low of $7.85. The stock managed 5.13% rise and now stands at $11.06 as of 01/11/2019. At recent session, the prices were hovering between $10.3748 and $11.19. This company shares are 221.88% off its target price of $35.6 and the current market capitalization stands at $692.91M. The recent change has given its price a 3.12% lead over SMA 50 and -51.49% deficit over its 52-week high. The stock witnessed 2.22% gains, -1.69% declines and -27.48% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found DVAX’s volatility during a week at 5.75% and during a month it has been found around 7.83%.

Dynavax Technologies Corporation (DVAX) Top Holders

Institutional investors currently hold around $533 million or 79.1% in DVAX stock. Look at its top three institutional owners. State Street Corp owns $46.43 million in Dynavax Technologies Corporation, which represents roughly 6.7% of the company’s market cap and approximately 8.71% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 4,123,662 shares of the stock are valued at $45.61 million. The third largest holder is Franklin Resources Inc, which currently holds $34.69 million worth of this stock and that ownership represents nearly 5.01% of its market capitalization.

Dynavax Technologies Corporation 13F Filings

At the end of September reporting period, 65 institutional holders increased their position in Dynavax Technologies Corporation (NASDAQ:DVAX) by some 6,187,536 shares, 69 decreased positions by 10,243,094 and 36 held positions by 31,794,830. That puts total institutional holdings at 48,225,460 shares, according to SEC filings. The stock grabbed 17 new institutional investments totaling 525,403 shares while 23 institutional investors sold out their entire positions totaling 5,440,717 shares.

Dynavax Technologies Corporation (NASDAQ:DVAX) Insider Trades

Multiple company employees have indulged in significant insider trading. Dynavax Technologies Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Cano Francis has sold 2,000 shares of Dynavax Technologies Corporation (DVAX) in trading session dated Dec. 06, 2018. These shares are worth $20,940 and were traded at $10.47 each. The SEC filing shows that Ostrach Michael S performed a sale of 4,000 shares. The Senior Vice President disposed these shares by way of transaction on Jun. 08, 2018. The company’s shares were given away at $15.53 per share worth to an income of some $62,120 on account of Ostrach Michael S.

Senior Vice President, Novack David F, sold 16,109 common shares of Dynavax Technologies Corporation (DVAX) in the open market. In a transaction dated Mar. 15, 2018, the shares were put up for sale at an average price of $16.3, raking in a sum of $262,577. After this sale, common shares of DVAX are directly owned by the insider, with total stake valued at $.

In the transaction dated Mar. 13, 2018, the great number of shares disposed came courtesy the Senior Vice President; Novack David F disposed a total of 34,214 shares at an average price of $16.52, amounting to approximately $565,215. The insider now directly owns 16,109 shares worth $178,166.

Dynavax Technologies Corporation (DVAX) Analyst Guide

Several analysts have released their opinion on Dynavax Technologies Corporation (NASDAQ:DVAX), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 5 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.83 average brokerage recommendation.